İcLal Sena Gezer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
İcLal Sena Gezer has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Dilek Sahin
Perinatology Department Ankara Bilkent City Hospital Ankara Turkey
7 shared publications - Nuray Yazihan
Pathophysiology Department, Faculty of Medicine, Ankara University, Ankara, Turkey
7 shared publications - Atakan Tanacan
Perinatology Department Ankara Bilkent City Hospital Ankara Turkey
6 shared publications - Ayse Gulcin Bastemur
Perinatology Division, Department of Obstetrics and Gynecology Eskişehir City Hospital Eskişehir Turkey
6 shared publications - Burcu Bozkurt Özdal
Perinatology Department Ankara Bilkent City Hospital Ankara Turkey
3 shared publications - Burcu Kesikli
Department of Pathophysiology, Faculty of Medicine, Ankara University, Ankara, Turkey
3 shared publications
Latest Publications
- 30 October 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
First‐trimester trace‐element profiles in pregnant women with epilepsy: An exploratory prospective association between selenium and subsequent seizure recurrence
Objective: This study compares first‐trimester serum zinc, copper, selenium and zinc‐to‐copper ratios between pregnant women with pre‐existing epilepsy and healthy controls and assesses associations with subsequent seizure recurrence. Methods: This prospective controlled study included 48 pregnant women with pre‐existing epilepsy and 59 controls. All women with epilepsy had been seizure free for at least 2 years before conception. Trace elements were measured at 6–12 gestational weeks, before recurrence. Between‐group differences were assessed using multivariable linear regression adjusted for maternal age, body mass index, smoking, and gestational week at sampling. Seizure recurrence was evaluated using logistic regression adjusted for epilepsy duration and type. Results: Compared with controls, women with epilepsy had 9.1% higher zinc, 56.3% higher copper, 16.8% lower selenium, and a 30.2% lower zinc‐to‐copper ratio after adjustment; all remained significant after false discovery rate correction. During follow‐up, 20/48 women (41.7%) experienced recurrence. Selenium was lower in women with recurrence than in those who remained seizure free (36.53 [34.70–41.41] vs 46.36 [42.77–47.83] μg/L; P < 0.001), and each one‐standard deviation increase in selenium was associated with lower odds of subsequent seizure recurrence after adjustment for epilepsy duration and type (adjusted OR 0.11, 95% CI 0.03–0.37). Zinc, copper, and the zinc‐to‐copper ratio were not associated with recurrence. Conclusion: Pregnant women with epilepsy showed a distinct first‐trimester trace‐element profile. Lower first‐trimester selenium was prospectively associated with subsequent seizure recurrence; however, this exploratory finding requires external validation before any predictive or clinical interpretation.
- 30 October 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
First‐trimester trace‐element profiles in pregnant women with epilepsy: An exploratory prospective association between selenium and subsequent seizure recurrence
Objective: This study compares first‐trimester serum zinc, copper, selenium and zinc‐to‐copper ratios between pregnant women with pre‐existing epilepsy and healthy controls and assesses associations with subsequent seizure recurrence. Methods: This prospective controlled study included 48 pregnant women with pre‐existing epilepsy and 59 controls. All women with epilepsy had been seizure free for at least 2 years before conception. Trace elements were measured at 6–12 gestational weeks, before recurrence. Between‐group differences were assessed using multivariable linear regression adjusted for maternal age, body mass index, smoking, and gestational week at sampling. Seizure recurrence was evaluated using logistic regression adjusted for epilepsy duration and type. Results: Compared with controls, women with epilepsy had 9.1% higher zinc, 56.3% higher copper, 16.8% lower selenium, and a 30.2% lower zinc‐to‐copper ratio after adjustment; all remained significant after false discovery rate correction. During follow‐up, 20/48 women (41.7%) experienced recurrence. Selenium was lower in women with recurrence than in those who remained seizure free (36.53 [34.70–41.41] vs 46.36 [42.77–47.83] μg/L; P < 0.001), and each one‐standard deviation increase in selenium was associated with lower odds of subsequent seizure recurrence after adjustment for epilepsy duration and type (adjusted OR 0.11, 95% CI 0.03–0.37). Zinc, copper, and the zinc‐to‐copper ratio were not associated with recurrence. Conclusion: Pregnant women with epilepsy showed a distinct first‐trimester trace‐element profile. Lower first‐trimester selenium was prospectively associated with subsequent seizure recurrence; however, this exploratory finding requires external validation before any predictive or clinical interpretation.
- Open Access
- 24 July 2026
- Published by Springer Nature in Nutrire
- Vol. 51 (2) , 100
Evaluation of dietary inflammatory index and dietary antioxidant capacity with maternal inflammatory and oxidative markers in preeclampsia
- 24 July 2026
- Published by Springer Nature in Nutrire
- Vol. 51 (2) , 100
Open AccessEvaluation of dietary inflammatory index and dietary antioxidant capacity with maternal inflammatory and oxidative markers in preeclampsia
- Open Access
- 14 May 2026
- Published by Springer Nature in European Journal of Nutrition
- Vol. 65 (4) , 132
Amino acids: Missing link in preeclampsia pathogenesis?
Purpose: This study was designed to determine maternal dietary and serum amino acid (AA) levels as risk factors for preeclampsia (PE), aiming to identify the potential of specific AAs as biomarkers that could lead to novel dietary intervention strategies. Methods: This prospective observational study included a total of 84 pregnant women (27 with PE and 57 controls). Maternal serum AA profiles were quantified using liquid chromatography-mass spectrometry (LC–MS), and dietary AA intake was assessed via three-day dietary recalls, usual intake was estimated using the Multiple Source Method (MSM) to correct for within-person variability. The potential of AA as a risk factor was evaluated using the Receiver Operating Characteristic (ROC) curve analysis, and key mechanisms involved in AA metabolism were identified through pathway analysis. Results: Dietary assessment uncovered a altered dietary amino acid pattern (AUC > 0.8), characterized by low intake of arginine, alanine, and glycine, glutamic acid, histidine, proline, serine, threonine, and tryptophan, alongside high total branched-chain amino acid (BCAA) and leucine consumption. Although dietary total protein intake was lower in PE, a higher intake of animal protein was observed. Concurrently, serum glutamine, asparagine, phenylalanine, 3-methylhistidine, cysteine, threonine, valine, BCAA, EAA, and aromatic AAs (AUC > 0.8) in serum were found to be potential risk factors for PE. Our results establish that dietary AA patterns and serum AA changes are independent, key risk factors, together providing a more comprehensive etiological model of PE. Conclusion: This study showed that a dietary imbalance in specific AAs represents a modifiable risk factor for PE. This finding, alongside an altered serum AA profile, opens new avenues for targeted nutritional interventions in high-risk pregnancies.
- 14 May 2026
- Published by Springer Nature in European Journal of Nutrition
- Vol. 65 (4) , 132
Open AccessAmino acids: Missing link in preeclampsia pathogenesis?
Purpose: This study was designed to determine maternal dietary and serum amino acid (AA) levels as risk factors for preeclampsia (PE), aiming to identify the potential of specific AAs as biomarkers that could lead to novel dietary intervention strategies. Methods: This prospective observational study included a total of 84 pregnant women (27 with PE and 57 controls). Maternal serum AA profiles were quantified using liquid chromatography-mass spectrometry (LC–MS), and dietary AA intake was assessed via three-day dietary recalls, usual intake was estimated using the Multiple Source Method (MSM) to correct for within-person variability. The potential of AA as a risk factor was evaluated using the Receiver Operating Characteristic (ROC) curve analysis, and key mechanisms involved in AA metabolism were identified through pathway analysis. Results: Dietary assessment uncovered a altered dietary amino acid pattern (AUC > 0.8), characterized by low intake of arginine, alanine, and glycine, glutamic acid, histidine, proline, serine, threonine, and tryptophan, alongside high total branched-chain amino acid (BCAA) and leucine consumption. Although dietary total protein intake was lower in PE, a higher intake of animal protein was observed. Concurrently, serum glutamine, asparagine, phenylalanine, 3-methylhistidine, cysteine, threonine, valine, BCAA, EAA, and aromatic AAs (AUC > 0.8) in serum were found to be potential risk factors for PE. Our results establish that dietary AA patterns and serum AA changes are independent, key risk factors, together providing a more comprehensive etiological model of PE. Conclusion: This study showed that a dietary imbalance in specific AAs represents a modifiable risk factor for PE. This finding, alongside an altered serum AA profile, opens new avenues for targeted nutritional interventions in high-risk pregnancies.
- 17 February 2026
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 86 (2) , 181-191
Lower serum threonine and glutamine levels could be a predictor for multiple sclerosis in pregnancy
- 17 February 2026
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 86 (2) , 181-191
Lower serum threonine and glutamine levels could be a predictor for multiple sclerosis in pregnancy
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (4) , e20251979
Relation of inflammatory and oxidative biomarkers associated with relapse in pregnant women diagnosed with multiple sclerosis
SUMMARY OBJECTIVE: The aim of this study was to examine the relationship between inflammatory mediators (tumor necrosis factor-alpha, interleukin-6, and interleukin-10), oxidative stress parameters, and obstetric-neonatal outcomes in maternal blood of pregnant patients with multiple sclerosis and healthy pregnant patients, and to identify biomarkers that may be useful in predicting relapse in pregnant patients with multiple sclerosis. METHODS: This prospective, single-center study was conducted at Ankara City Hospital between July 2024 and May 2025 and included a total of 72 patients: 36 pregnant women diagnosed with multiple sclerosis and 36 healthy pregnant women as the control group. The patients with multiple sclerosis were further divided into two groups: those who experienced relapses during pregnancy and those who did not. Clinical and demographic data, biochemical tests (interleukin-6, interleukin-10, tumor necrosis factor-alpha, total antioxidant status, and total oxidant status), and obstetric and neonatal outcomes were recorded. Data were analyzed statistically using SPSS 22.0, and appropriate statistical tests and correlation analyses were applied. RESULTS: Levels of interleukin-6, interleukin-10, tumor necrosis factor-alpha, total oxidant status, and total antioxidant status were significantly higher in patients with multiple sclerosis compared to controls (p<0.01). These parameters were even more elevated in patients who experienced relapses. Receiver operating characteristic analysis demonstrated that cut-off values of 237.8 pg/mL for tumor necrosis factor-alpha and 1.75 for interleukin-6/interleukin-10 provided high sensitivity and specificity in predicting multiple sclerosis relapse. CONCLUSION: Inflammatory and oxidative stress markers were elevated in pregnant women with multiple sclerosis, and tumor necrosis factor-alpha levels and the interleukin-6/interleukin-10 ratio were identified as potential biomarkers for predicting disease relapse.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (4) , e20251979
Open AccessRelation of inflammatory and oxidative biomarkers associated with relapse in pregnant women diagnosed with multiple sclerosis
SUMMARY OBJECTIVE: The aim of this study was to examine the relationship between inflammatory mediators (tumor necrosis factor-alpha, interleukin-6, and interleukin-10), oxidative stress parameters, and obstetric-neonatal outcomes in maternal blood of pregnant patients with multiple sclerosis and healthy pregnant patients, and to identify biomarkers that may be useful in predicting relapse in pregnant patients with multiple sclerosis. METHODS: This prospective, single-center study was conducted at Ankara City Hospital between July 2024 and May 2025 and included a total of 72 patients: 36 pregnant women diagnosed with multiple sclerosis and 36 healthy pregnant women as the control group. The patients with multiple sclerosis were further divided into two groups: those who experienced relapses during pregnancy and those who did not. Clinical and demographic data, biochemical tests (interleukin-6, interleukin-10, tumor necrosis factor-alpha, total antioxidant status, and total oxidant status), and obstetric and neonatal outcomes were recorded. Data were analyzed statistically using SPSS 22.0, and appropriate statistical tests and correlation analyses were applied. RESULTS: Levels of interleukin-6, interleukin-10, tumor necrosis factor-alpha, total oxidant status, and total antioxidant status were significantly higher in patients with multiple sclerosis compared to controls (p<0.01). These parameters were even more elevated in patients who experienced relapses. Receiver operating characteristic analysis demonstrated that cut-off values of 237.8 pg/mL for tumor necrosis factor-alpha and 1.75 for interleukin-6/interleukin-10 provided high sensitivity and specificity in predicting multiple sclerosis relapse. CONCLUSION: Inflammatory and oxidative stress markers were elevated in pregnant women with multiple sclerosis, and tumor necrosis factor-alpha levels and the interleukin-6/interleukin-10 ratio were identified as potential biomarkers for predicting disease relapse.
- Open Access
- 14 May 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-9
The influence of dietary choices: investigation of the relationship dietary inflammatory index and fetal growth restriction
Fetal growth restriction (FGR) is characterized by the fetus’s inability to reach its growth potential and affecting approximately 10% of the population. The etiology of late-onset FGR, which occurs after 32 weeks, is unclear but may be influenced by maternal weight. A proinflammatory diet can cause chronic inflammation and, Dietary Inflammatory Index (DII) was developed to evaluate of the diet’s impact on inflammation. A high DII indicates a pro-inflammatory diet, known to increase serum inflammatory markers, with oxidative stress playing a key role in inflammatory diseases. The study aimed to investigate the correlation between maternal DII, total oxidant status (TOS), total antioxidant status (TAS), interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor-alpha (TNF-α) levels in FGR-diagnosed pregnant women. This prospective-observational study included FGR-diagnosed pregnant women and healthy pregnant women with gestational ages of 32–38 weeks (n = 23 per group). Chronic diseases, hypertension, fetal anomalies, membrane ruptures, and multiple pregnancies were excluded. The DII was calculated using the BeBiS-9 program based on 3-day dietary records kept by an expert dietician. Blood samples were collected, centrifuged, and analyzed for IL-6, TNF-α, IL-10, TAS, and TOS. The study group had significantly higher DII scores (p < 0.001), lower energy (p = 0.004), carbohydrate (p = 0.002), protein (p = 0.011), fiber (p < 0.001) intake than the control group. TNF-α levels were elevated in the FGR group (p < 0.001), while IL-6 levels were higher but not statistically significant (p = 0.06). IL-10 levels were lower in the study group (p = 0.05). TAS, TOS, and TAS/TOS levels showed no significant differences between groups. Logistic regression indicated a 62% increase in FGR probability with higher DII levels (p = 0.001, CI 1.209–2.195). Correlation analysis revealed a strong positive correlation between DII and maternal serum TNF-α (r = 0.375, p = 0.01) and a strong negative correlation between birth weight and TNF-α (r=-0.478, p < 0.001) and DII (r=-0.446, p = 0.002). This study showed that a pro-inflammatory maternal diet increased dietary inflammatory index and increased maternal inflammatory markers, and this was more significant in fetuses with FGR than in normal weight fetuses.
- 14 May 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-9
Open AccessThe influence of dietary choices: investigation of the relationship dietary inflammatory index and fetal growth restriction
Fetal growth restriction (FGR) is characterized by the fetus’s inability to reach its growth potential and affecting approximately 10% of the population. The etiology of late-onset FGR, which occurs after 32 weeks, is unclear but may be influenced by maternal weight. A proinflammatory diet can cause chronic inflammation and, Dietary Inflammatory Index (DII) was developed to evaluate of the diet’s impact on inflammation. A high DII indicates a pro-inflammatory diet, known to increase serum inflammatory markers, with oxidative stress playing a key role in inflammatory diseases. The study aimed to investigate the correlation between maternal DII, total oxidant status (TOS), total antioxidant status (TAS), interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor-alpha (TNF-α) levels in FGR-diagnosed pregnant women. This prospective-observational study included FGR-diagnosed pregnant women and healthy pregnant women with gestational ages of 32–38 weeks (n = 23 per group). Chronic diseases, hypertension, fetal anomalies, membrane ruptures, and multiple pregnancies were excluded. The DII was calculated using the BeBiS-9 program based on 3-day dietary records kept by an expert dietician. Blood samples were collected, centrifuged, and analyzed for IL-6, TNF-α, IL-10, TAS, and TOS. The study group had significantly higher DII scores (p < 0.001), lower energy (p = 0.004), carbohydrate (p = 0.002), protein (p = 0.011), fiber (p < 0.001) intake than the control group. TNF-α levels were elevated in the FGR group (p < 0.001), while IL-6 levels were higher but not statistically significant (p = 0.06). IL-10 levels were lower in the study group (p = 0.05). TAS, TOS, and TAS/TOS levels showed no significant differences between groups. Logistic regression indicated a 62% increase in FGR probability with higher DII levels (p = 0.001, CI 1.209–2.195). Correlation analysis revealed a strong positive correlation between DII and maternal serum TNF-α (r = 0.375, p = 0.01) and a strong negative correlation between birth weight and TNF-α (r=-0.478, p < 0.001) and DII (r=-0.446, p = 0.002). This study showed that a pro-inflammatory maternal diet increased dietary inflammatory index and increased maternal inflammatory markers, and this was more significant in fetuses with FGR than in normal weight fetuses.